GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Tongrentang Co Ltd (SHSE:600085) » Definitions » Beneish M-Score

Beijing Tongrentang Co (SHSE:600085) Beneish M-Score : -2.36 (As of May. 16, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Beijing Tongrentang Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.36 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Beijing Tongrentang Co's Beneish M-Score or its related term are showing as below:

SHSE:600085' s Beneish M-Score Range Over the Past 10 Years
Min: -3.12   Med: -2.66   Max: -1.97
Current: -2.36

During the past 13 years, the highest Beneish M-Score of Beijing Tongrentang Co was -1.97. The lowest was -3.12. And the median was -2.66.


Beijing Tongrentang Co Beneish M-Score Historical Data

The historical data trend for Beijing Tongrentang Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tongrentang Co Beneish M-Score Chart

Beijing Tongrentang Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.86 -2.93 -2.86 -2.70 -2.71

Beijing Tongrentang Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.66 -2.76 -2.67 -2.71 -2.36

Competitive Comparison of Beijing Tongrentang Co's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Tongrentang Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Tongrentang Co's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Tongrentang Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Beijing Tongrentang Co's Beneish M-Score falls into.



Beijing Tongrentang Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Beijing Tongrentang Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8347+0.528 * 1.0427+0.404 * 0.9695+0.892 * 1.0859+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9414+4.679 * 0.039966-0.327 * 1.0294
=-2.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ¥2,100 Mil.
Revenue was 5267.289 + 4139.511 + 3960.684 + 4617.627 = ¥17,985 Mil.
Gross Profit was 2261.332 + 2095.964 + 1851.124 + 2108.408 = ¥8,317 Mil.
Total Current Assets was ¥24,334 Mil.
Total Assets was ¥31,253 Mil.
Property, Plant and Equipment(Net PPE) was ¥5,619 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥3,628 Mil.
Total Current Liabilities was ¥6,471 Mil.
Long-Term Debt & Capital Lease Obligation was ¥3,348 Mil.
Net Income was 575.878 + 278.142 + 404.166 + 463.171 = ¥1,721 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was -251.766 + -524.85 + 27.566 + 1221.348 = ¥472 Mil.
Total Receivables was ¥2,317 Mil.
Revenue was 5143.07 + 4472.144 + 3393.268 + 3553.312 = ¥16,562 Mil.
Gross Profit was 2391.324 + 2227.894 + 1540.231 + 1826.357 = ¥7,986 Mil.
Total Current Assets was ¥21,471 Mil.
Total Assets was ¥27,914 Mil.
Property, Plant and Equipment(Net PPE) was ¥5,246 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥3,549 Mil.
Total Current Liabilities was ¥6,389 Mil.
Long-Term Debt & Capital Lease Obligation was ¥2,131 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2100.152 / 17985.111) / (2316.811 / 16561.794)
=0.116772 / 0.139889
=0.8347

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(7985.806 / 16561.794) / (8316.828 / 17985.111)
=0.482182 / 0.462429
=1.0427

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (24333.892 + 5619.451) / 31253.027) / (1 - (21470.966 + 5245.963) / 27914.338)
=0.041586 / 0.042896
=0.9695

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=17985.111 / 16561.794
=1.0859

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 5245.963)) / (0 / (0 + 5619.451))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(3627.885 / 17985.111) / (3548.565 / 16561.794)
=0.201716 / 0.214262
=0.9414

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3348.384 + 6471.118) / 31253.027) / ((2130.766 + 6389.01) / 27914.338)
=0.314194 / 0.305211
=1.0294

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1721.357 - 0 - 472.298) / 31253.027
=0.039966

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Beijing Tongrentang Co has a M-score of -2.36 suggests that the company is unlikely to be a manipulator.


Beijing Tongrentang Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Beijing Tongrentang Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Tongrentang Co (SHSE:600085) Business Description

Traded in Other Exchanges
N/A
Address
No. 52 Dong Xing Long Street, Chongwen District, Beijing, Beijing, CHN, 100062
Beijing Tongrentang Co Ltd is a China-based company operating in the traditional Chinese medicinal industry. The company produces modern pharmaceuticals and operates retail businesses and medical services. Its products are Children Qingfei oral liquid, Rana oil granules, Ejiao, and others.

Beijing Tongrentang Co (SHSE:600085) Headlines

No Headlines